Fabry Disease Simulating Crohn's Ileitis

被引:0
作者
Rubio, Carlos A. [1 ]
Villnow, Elizabeth [1 ]
Sundelin, Birgitta [1 ]
Eriksson, Elina [1 ]
Dolapcsiev, Karoli [1 ]
Bjork, Jan [2 ]
Befrits, Ragnar [2 ]
Tengvar, Magnus [3 ]
Iversen, Henrik [4 ]
机构
[1] Karolinska Univ Hosp, Dept Pathol, Stockholm, Sweden
[2] Karolinska Univ Hosp, Dept Gastroenterol, Stockholm, Sweden
[3] Karolinska Univ Hosp, Dept Radiol, Stockholm, Sweden
[4] Karolinska Univ Hosp, Dept Surg Gastroenterol, Stockholm, Sweden
关键词
Fabry disease; small bowel; bi-refringent lamellar deposits; calcifications; Crohn-like; ENZYME REPLACEMENT THERAPY; AGALSIDASE BETA; PERFORATION;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Fabry disease is an inherited (X-linked) lysosomal storage disorder caused by deficiency of a-galactosidase A, leading to accumulation of globotriaosylceramide in various tissues. A 57-year-old male with a family history and laboratory findings of Fabry disease, was consulted for severe abdominal pain, undulating pyrexia, weight loss and diarrhea. The tentative clinical diagnosis of Crohn's ileitis was supported at computed tomographic examination, at laparotomy and at inspection of the resected ileal segment. Histology revealed chronic and acute inflammation, thick-walled occluded vessels, fibrosis and characteristic bi-refringent lamellar deposits of globotriaosylceramide and calcifications. Multi-nucleated giant cells contained phagocytized bi-refringent material. Transmission electron microscopy showed cells with irregular cytoplasmic bodies displaying distinctive zebra-like lamellar structures. It is submitted that the gastrointestinal phenotype of Fabry disease may concur with symptoms resembling abdominal Crohn's disease.
引用
收藏
页码:2437 / 2441
页数:5
相关论文
共 19 条
  • [1] ALROY J, 2002, J AM SOC NEPHROL S2, V13
  • [2] [Anonymous], FABRY DIS PERSPECTIV
  • [3] Neurological aspects of Fabry disease
    Besson, G
    Clavelou, P
    Germain, DP
    [J]. M S-MEDECINE SCIENCES, 2005, 21 : 26 - 29
  • [4] SMALL BOWEL PERFORATION IN FABRYS-DISEASE
    BRYAN, A
    KNAUFT, RF
    BURNS, WA
    [J]. ANNALS OF INTERNAL MEDICINE, 1977, 86 (03) : 315 - 316
  • [5] Buda P, 2012, JIMD REP, V4, P25, DOI 10.1007/8904_2011_63
  • [6] EFFECTS OF FAT-SOLUBLE COMPOUNDS ON LYSOSOMES IN VITRO
    DUVE, CD
    WIBO, M
    WATTIAUX, R
    [J]. BIOCHEMICAL PHARMACOLOGY, 1962, 9 (AUG) : 97 - &
  • [7] Fabry disease: a morphologic study of 11 cases
    Fischer, Edgar G.
    Moore, Michael J.
    Lager, Donna J.
    [J]. MODERN PATHOLOGY, 2006, 19 (10) : 1295 - 1301
  • [8] FRIEDMAN LS, 1984, GASTROENTEROLOGY, V86, P558
  • [9] Fuller M, 2006, FABRY DIS PERSPECTIV
  • [10] Gastrointestinal symptoms in 342 patients with Fabry disease: Prevalence and response to enzyme replacement therapy
    Hoffmann, Bjoern
    Schwarz, Martin
    Mehta, Atul
    Keshav, Satish
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2007, 5 (12) : 1447 - 1453